What we're exploring next.

Stroke & cerebral microbleeds
Susceptibility and relaxation-based outputs being explored for acute and chronic cerebrovascular assessment.
Neuro-oncology
Quantitative tissue characterization being evaluated for tumor margin and treatment-response contexts.
CNS disorders
Broader neurodegenerative and CNS applications building on the same physics-based measurement approach.
Pediatrics
Extending vendor-agnostic, standardized acquisition to pediatric neuroimaging protocols.